Retatrutide Injection – obesity and type 2 diabetes drug therapy in India.
It is a single molecule that acts as a triple agonist for GLP-1, GIP, and glucagon receptors. It is a powerful “triple-threat” metabolic peptide for weight loss and obesity management.
| Brand Name: | Retatrutide Pen |
| Strength: | Triple Agonist for GLP-1, GIP, and Glucagon Receptors |
| Manufacturer: | Regenmed |
| Price: | On Request |
Retatrutide must always be used under the supervision of a Registered Medical Practitioner (RMP).
Retatrutide is an investigational drug, currently only available through legitimate clinical trials, with Phase 3 trials concluding in 2026.
IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to Retatrutide Injection for personal use. For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.
